Boston
Jeremy advises clients on the full range of regulatory health care issues facing digital health stakeholders. His depth and breadth of experience enables him to help established and early-stage companies navigate a complex and ever-changing business and regulatory landscape. As one client’s CEO explained, “Jeremy is one of the best thought partners, and hands down the best legal navigator, I’ve found in the digital health space.”
His telehealth experience includes advising on compliance with state licensure requirements for physicians and non-physician practitioners, corporate practice of medicine issues, remote prescribing (including controlled substances), patient consent and Medicare, Medicaid and commercial reimbursement. He advises clients on compliance with laws against fraud and abuse, including federal and state anti-kickback and self-referral laws, as well as privacy issues arising under HIPAA and its state-level counterparts.
Jeremy has substantial experience pertaining to structuring, operationalizing and scaling “PC-MSO” arrangements across all 50 states. He also advises venture capital and private equity firms conducting regulatory diligence associated with investments in digital health and health care technology ventures, from seed stage funding to nine-figure raises.
Boston
Jeremy advises clients on the full range of regulatory health care issues facing digital health stakeholders. His depth and breadth of experience enables him to help established and early-stage companies navigate a complex and ever-changing business and regulatory landscape. As one client’s CEO explained, “Jeremy is one of the best thought partners, and hands down the best legal navigator, I’ve found in the digital health space.”
His telehealth experience includes advising on compliance with state licensure requirements for physicians and non-physician practitioners, corporate practice of medicine issues, remote prescribing (including controlled substances), patient consent and Medicare, Medicaid and commercial reimbursement. He advises clients on compliance with laws against fraud and abuse, including federal and state anti-kickback and self-referral laws, as well as privacy issues arising under HIPAA and its state-level counterparts.
Jeremy has substantial experience pertaining to structuring, operationalizing and scaling “PC-MSO” arrangements across all 50 states. He also advises venture capital and private equity firms conducting regulatory diligence associated with investments in digital health and health care technology ventures, from seed stage funding to nine-figure raises.
Boston
Jake counsels visionary founders and top-tier venture and growth equity funds on venture financings, complex M&A, corporate governance, strategic collaborations, and other mission-critical transactions. Known for his steady counsel and deep market knowledge, Jake helps emerging companies scale with confidence and investors deploy capital with clarity.
Jake’s experience also includes representation of top growth equity and venture capital funds in the execution of their deals and deployment of capital, including work with TPG Capital, 5AM Ventures, and Pillar VC, among others.
He is currently a member of the Board of Trustees for the Leukemia and Lymphoma Society (New England) and is an active member of the Boston venture and emerging company ecosystem, including frequent speaking engagements for founders and other stakeholders on entrepreneurship, capital formation, and strategic transaction matters.
Prior to joining Orrick, Jake worked with Wilson Sonsini Goodrich & Rosati in its Boston office upon its founding. He lives in Boston with his wife Emily, an oncologist here in Boston, and their daughter Mia.
Boston
Jake counsels visionary founders and top-tier venture and growth equity funds on venture financings, complex M&A, corporate governance, strategic collaborations, and other mission-critical transactions. Known for his steady counsel and deep market knowledge, Jake helps emerging companies scale with confidence and investors deploy capital with clarity.
Jake’s experience also includes representation of top growth equity and venture capital funds in the execution of their deals and deployment of capital, including work with TPG Capital, 5AM Ventures, and Pillar VC, among others.
He is currently a member of the Board of Trustees for the Leukemia and Lymphoma Society (New England) and is an active member of the Boston venture and emerging company ecosystem, including frequent speaking engagements for founders and other stakeholders on entrepreneurship, capital formation, and strategic transaction matters.
Prior to joining Orrick, Jake worked with Wilson Sonsini Goodrich & Rosati in its Boston office upon its founding. He lives in Boston with his wife Emily, an oncologist here in Boston, and their daughter Mia.
Boston
Albert is involved in a broad range of corporate legal engagements for high growth technology companies, including IPOs, follow-on public offerings, private and public company securities law compliance matters, public company disclosure obligations, venture financings, mergers and acquisitions, de-SPAC transactions and SPAC IPOs. He also regularly advises public and private companies and their boards of directors on corporate governance issues.
Albert's clients include public and private companies in technology, energy, automotive, Internet related industries, real estate, finance and the life sciences (including, among others, immuno-oncology, gene therapy, restorative cell therapy and medical device companies). He also represents underwriters in initial public offerings, follow-on offerings and PIPE offerings and venture capital firms in a variety of investment transactions.
Albert was named to the Deal’s Top Rising Stars 2021 list, which recognizes top new partners at U.S. law firms who are “doing spectacular work in the field of deal-making and who have continued to progress in their career despite the obstacles put in front of them.”
Boston
Albert is involved in a broad range of corporate legal engagements for high growth technology companies, including IPOs, follow-on public offerings, private and public company securities law compliance matters, public company disclosure obligations, venture financings, mergers and acquisitions, de-SPAC transactions and SPAC IPOs. He also regularly advises public and private companies and their boards of directors on corporate governance issues.
Albert's clients include public and private companies in technology, energy, automotive, Internet related industries, real estate, finance and the life sciences (including, among others, immuno-oncology, gene therapy, restorative cell therapy and medical device companies). He also represents underwriters in initial public offerings, follow-on offerings and PIPE offerings and venture capital firms in a variety of investment transactions.
Albert was named to the Deal’s Top Rising Stars 2021 list, which recognizes top new partners at U.S. law firms who are “doing spectacular work in the field of deal-making and who have continued to progress in their career despite the obstacles put in front of them.”
Boston
Catherine's practice focuses on buy-side and sell-side mergers and acquisitions, both domestic and cross-border. She practices across a variety of industries, including energy, technology and software, healthcare and life sciences. As a member of the firm's EnergyTech team, Catherine focuses on advising companies developing next-generation technologies in energy storage, carbon capture, alternative fuels and agtech.
Boston
Catherine's practice focuses on buy-side and sell-side mergers and acquisitions, both domestic and cross-border. She practices across a variety of industries, including energy, technology and software, healthcare and life sciences. As a member of the firm's EnergyTech team, Catherine focuses on advising companies developing next-generation technologies in energy storage, carbon capture, alternative fuels and agtech.
Boston
Anna advises clients on meeting the complex requirements of federal, state, and international privacy frameworks, with particular focus on the needs of cross-border projects.
Prior to joining Orrick, Anna practiced as a barrister in London for ten years, representing clients in cross-border disputes and enforcement proceedings, both in court and international arbitration. Her experience has included matters in India, Japan, Russia, Egypt, Australia, Thailand, and Europe.
Boston
Anna advises clients on meeting the complex requirements of federal, state, and international privacy frameworks, with particular focus on the needs of cross-border projects.
Prior to joining Orrick, Anna practiced as a barrister in London for ten years, representing clients in cross-border disputes and enforcement proceedings, both in court and international arbitration. Her experience has included matters in India, Japan, Russia, Egypt, Australia, Thailand, and Europe.
Boston
Tori advises clients on enhancing their data privacy and security profiles and building comprehensive global data protection programs. She provides guidance on issues relating to a vast array of state, federal and international privacy and cybersecurity laws, including:
Tori also supports clients in developing strategies to reduce the risk of security incidents, regularly advises on general consumer protection issues, and counsels on sweepstakes, marketing, and advertising matters.
Prior to joining Orrick, Tori served as an in-house data privacy and security law clerk at a pharmaceutical company in Boston, at a large nonprofit corporation in New York City, and at an international oil and gas company in Beijing. She also worked on data privacy matters in the Office of the General Counsel of Northeastern University. Having worked across diverse business sectors, including life sciences, technology and energy, Tori brings an in-house perspective to her client matters.
Boston
Tori advises clients on enhancing their data privacy and security profiles and building comprehensive global data protection programs. She provides guidance on issues relating to a vast array of state, federal and international privacy and cybersecurity laws, including:
Tori also supports clients in developing strategies to reduce the risk of security incidents, regularly advises on general consumer protection issues, and counsels on sweepstakes, marketing, and advertising matters.
Prior to joining Orrick, Tori served as an in-house data privacy and security law clerk at a pharmaceutical company in Boston, at a large nonprofit corporation in New York City, and at an international oil and gas company in Beijing. She also worked on data privacy matters in the Office of the General Counsel of Northeastern University. Having worked across diverse business sectors, including life sciences, technology and energy, Tori brings an in-house perspective to her client matters.